Home
Science & Medicine
Diagnostic Oncology
Evolving Standards of Care
FDA Corner
Global Initiatives
Immunotherapy
Lung Cancer Screening
NCI Corner
Pathology
Prevention and Tobacco Control
Radiation Oncology
Supportive Care
Targeted Therapy
Advocacy & Survivorship
Thought-Leader Perspective
Allied Health
Meetings
Highlights
Preview
News
Breaking News Briefs
In Memoriam
People
Search
IASLC.org
IASLC Lung Cancer News
Home
Science & Medicine
Diagnostic Oncology
Evolving Standards of Care
FDA Corner
Global Initiatives
Immunotherapy
Lung Cancer Screening
NCI Corner
Pathology
Prevention and Tobacco Control
Radiation Oncology
Supportive Care
Targeted Therapy
Advocacy & Survivorship
Thought-Leader Perspective
Allied Health
Meetings
Highlights
Preview
News
Breaking News Briefs
In Memoriam
People
Home
Authors
Posts by lungcanc
lungcanc
526 POSTS
0 COMMENTS
Impact of COVID-19 on the Diagnostic Workup of Lung Cancer
lungcanc
Systemic Therapy for Advanced Stage Lung Cancer During the COVID-19 Pandemic
lungcanc
Impact of COVID-19 on Treatment of Lung Cancer Patients with Local...
lungcanc
Practical Practice Recommendations for Lung Cancer Radiotherapy During the COVID-19 Pandemic:...
lungcanc
Member Story: Suraj Samtani Bassarmal
lungcanc
U.S. Drug Approvals: 2010 – 2020
lungcanc
Milestones in Lung Cancer Treatment
lungcanc
Disparities in Meeting Eligibility Criteria for Lung Cancer Screening
lungcanc
Time to End the Debate on Genomic Testing in NSCLC
lungcanc
Stunning Progress Achieved in Lung Cancer Treatment Over the Last Decade
lungcanc
1
...
6
7
8
...
53
Page 7 of 53
Meeting News
Leora Horn, MD – IASLC Virtual Presidential Symposium Presentation
Paul Baas, MD – IASLC Virtual Presidential Symposium Presentation
TRACERx Data Show That Tracking MRD With ctDNA Heralds Disease Relapse
cfDNA Analysis Suggests EML4-ALK Variant Does Not Influence Response to Lorlatinib
Load more
Edit with Live CSS
